Zhejiang Taimei Medical Technology Co., Ltd. (HKG:2576)
Hong Kong · Delayed Price · Currency is HKD 4.460
+0.030 (0.68%)
Jan 23, 2026, 4:08 PM HKT
HKG:2576 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| 522.59 | 551.16 | 573.14 | 549.22 | 466.18 | 302.95 | Upgrade | |
Revenue Growth (YoY) | -8.82% | -3.84% | 4.36% | 17.81% | 53.88% | 61.68% | Upgrade |
Cost of Revenue | 308.41 | 326.21 | 394.14 | 363.81 | 301.85 | 178.65 | Upgrade |
Gross Profit | 214.19 | 224.94 | 179 | 185.4 | 164.33 | 124.31 | Upgrade |
Selling, General & Admin | 235.89 | 408.99 | 419.12 | 473.79 | 446.23 | 516.06 | Upgrade |
Research & Development | 73.84 | 87.05 | 169.19 | 208.18 | 190.84 | 108.99 | Upgrade |
Other Operating Expenses | -4.55 | -9.64 | -16.24 | -15.69 | -13.56 | -6.87 | Upgrade |
Operating Expenses | 308.77 | 489.99 | 580.4 | 670.84 | 626.92 | 619.63 | Upgrade |
Operating Income | -94.58 | -265.05 | -401.4 | -485.44 | -462.59 | -495.32 | Upgrade |
Interest Expense | -1.06 | -0.73 | -1.43 | -2.68 | -2.71 | -1.07 | Upgrade |
Interest & Investment Income | 40.1 | 37.05 | 41.65 | 22.88 | 28.74 | 24.33 | Upgrade |
Currency Exchange Gain (Loss) | -3.87 | 17.48 | 8.65 | 54.03 | -7.96 | -22.85 | Upgrade |
Other Non Operating Income (Expenses) | - | - | - | 1.27 | -0.82 | -0.46 | Upgrade |
EBT Excluding Unusual Items | -59.41 | -211.25 | -352.53 | -409.94 | -445.33 | -495.37 | Upgrade |
Impairment of Goodwill | -9.8 | -9.8 | -8.37 | -22.38 | -54.09 | -29.48 | Upgrade |
Gain (Loss) on Sale of Investments | -2.07 | 3.76 | 5.84 | 9.79 | 19.8 | - | Upgrade |
Gain (Loss) on Sale of Assets | -0.17 | -0.17 | - | -0.47 | 0.02 | 0.01 | Upgrade |
Asset Writedown | - | - | -1.2 | - | - | -0 | Upgrade |
Other Unusual Items | 0.04 | 0.04 | -0.11 | 0.42 | - | - | Upgrade |
Pretax Income | -71.4 | -217.41 | -356.36 | -422.58 | -479.61 | -524.85 | Upgrade |
Income Tax Expense | - | - | 0.02 | - | 0.01 | -0.47 | Upgrade |
Earnings From Continuing Operations | -71.4 | -217.41 | -356.38 | -422.58 | -479.61 | -524.38 | Upgrade |
Minority Interest in Earnings | 5.11 | 2.8 | 9.6 | 9.67 | - | - | Upgrade |
Net Income | -66.29 | -214.61 | -346.78 | -412.91 | -479.61 | -524.38 | Upgrade |
Net Income to Common | -66.29 | -214.61 | -346.78 | -412.91 | -479.61 | -524.38 | Upgrade |
Shares Outstanding (Basic) | 557 | 544 | 538 | 538 | 538 | 467 | Upgrade |
Shares Outstanding (Diluted) | 557 | 544 | 538 | 538 | 538 | 467 | Upgrade |
Shares Change (YoY) | 3.50% | 1.10% | - | - | 15.22% | - | Upgrade |
EPS (Basic) | -0.12 | -0.39 | -0.64 | -0.77 | -0.89 | -1.12 | Upgrade |
EPS (Diluted) | -0.12 | -0.39 | -0.64 | -0.77 | -0.89 | -1.12 | Upgrade |
Free Cash Flow | -122.25 | -207.3 | -355.52 | -353.62 | -247.63 | -109.62 | Upgrade |
Free Cash Flow Per Share | -0.22 | -0.38 | -0.66 | -0.66 | -0.46 | -0.23 | Upgrade |
Gross Margin | 40.98% | 40.81% | 31.23% | 33.76% | 35.25% | 41.03% | Upgrade |
Operating Margin | -18.10% | -48.09% | -70.04% | -88.39% | -99.23% | -163.50% | Upgrade |
Profit Margin | -12.68% | -38.94% | -60.50% | -75.18% | -102.88% | -173.09% | Upgrade |
Free Cash Flow Margin | -23.39% | -37.61% | -62.03% | -64.39% | -53.12% | -36.19% | Upgrade |
EBITDA | -86.45 | -248.66 | -378.66 | -463.41 | -451.58 | -493.89 | Upgrade |
EBITDA Margin | -16.54% | -45.12% | -66.07% | -84.38% | -96.87% | -163.02% | Upgrade |
D&A For EBITDA | 8.14 | 16.39 | 22.74 | 22.03 | 11 | 1.43 | Upgrade |
EBIT | -94.58 | -265.05 | -401.4 | -485.44 | -462.59 | -495.32 | Upgrade |
EBIT Margin | -18.10% | -48.09% | -70.04% | -88.39% | -99.23% | -163.50% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.